This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Tc Lending, LLC, as Collateral Agent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peter Benedict Kirk: Innovator in Bioconjugate Chemistry.
Introduction
Peter Benedict Kirk is a notable inventor based in the United States. He has made significant contributions to the field of bioconjugate chemistry, particularly in the development of innovative conjugates that combine IL-15 moieties with water-soluble polymers.
Latest Patents
Peter Kirk holds a patent for "Conjugates Of An IL-15 Moiety And A Polymer." This patent describes conjugates of an IL-15 moiety and one or more nonpeptidic, water-soluble polymers. Typically, the nonpeptidic, water-soluble polymer is poly(ethylene glycol) or a derivative thereof. The patent also includes compositions comprising these conjugates, methods of making them, and methods of administering the compositions to individuals.
Career Highlights
Throughout his career, Peter Kirk has focused on advancing the understanding and application of bioconjugates in therapeutic settings. His work has the potential to enhance the efficacy of treatments involving IL-15, a cytokine that plays a crucial role in immune response.
Collaborations
Peter Kirk has collaborated with Thomas Chang, a fellow innovator in the field. Their partnership has contributed to the development of novel bioconjugate technologies that may lead to improved therapeutic options.
Conclusion
Peter Benedict Kirk is a prominent figure in the realm of bioconjugate chemistry, with a focus on innovative applications of IL-15 moieties. His work continues to pave the way for advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile